Health Catalyst (HCAT) Misses Q2 EPS by 58c

Health Catalyst (NASDAQ: HCAT) reported Q2 EPS of ($0.55), $0.58 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $70.4 million versus the consensus estimate of $68.97 million.

For earnings history and earnings-related data on Health Catalyst (HCAT) click here.

You May Also Be Interested In

• Oracle reports earnings today: AI spending bet faces its toughest test yet
• Diamondrock Hospitality (DRH) PT Raised to $13.50 at Stifel
• PayPal (PYPL) call put ratio 1 call to 1.9 puts with a focus on 8K contracts of September 49 puts